bovin
coronaviru
bcv
member
coronavirida
possess
singlestrand
nonseg
rna
genom
posit
polar
virion
contain
four
major
structur
protein
nucleocapsid
protein
n
transmembran
glycoprotein
spike
glycoprotein
hemagglutininesteras
glycoprotein
bcv
bind
receptor
erythrocyt
possess
receptordestroy
enzym
similar
hef
glycoprotein
influenza
c
viru
receptordestroy
activ
hef
protein
associ
acetylesteras
ae
hydrolyz
ester
linkag
releas
acetyl
group
posit
acid
residu
crucial
influenza
c
viru
recognit
glycoprotein
receptor
major
determin
viral
attach
cell
initi
viral
infect
analog
influenza
c
viru
bcv
probabl
involv
viru
attach
entri
infecti
process
addit
glycoprotein
recent
bcv
protein
shown
induc
neutral
antibodi
vitro
viva
four
neutral
epitop
found
protein
bcvquebec
strain
howev
locat
function
properti
receptorbind
receptordestroy
activ
defin
protein
nglycosyl
molecular
weight
sequenc
data
articl
deposit
embvgenbank
librari
access
no
reprint
request
address
kda
reduc
form
exist
disulfidelink
homodim
kda
unreduc
form
interestingli
protein
present
coronavirus
human
coronaviru
hcv
hemagglutin
encephalomyel
viru
swine
turkey
enter
coronaviru
other
avian
infecti
bronchiti
viru
ibv
porcin
transmiss
gastroenter
viru
felin
infecti
periton
viru
lack
protein
genom
mous
hepat
viru
mhv
contain
open
read
frame
orf
code
protein
howev
protein
express
infect
cell
protein
mhvjhm
shown
ae
activ
assum
gene
requir
viral
infect
mhvjhm
clearli
role
glycoprotein
coronaviru
evolut
replic
pathogenesi
remain
enigmat
studi
role
glycoprotein
bcv
infect
sequenc
clone
gene
one
virul
one
avirul
bcv
strain
report
complet
nucleotid
predict
amino
acid
sequenc
gene
comparison
recent
publish
gene
sequenc
quebec
mebu
strain
also
investig
biolog
function
antigen
glycoprotein
virul
avirul
strain
use
monoclon
antibodi
mab
strain
deriv
bcvmebu
passag
differ
nonpolar
highli
polar
cell
passag
highli
virul
wildtyp
strain
bcvli
isol
fluid
diseas
calf
utah
maintain
calv
oral
inocul
sinc
strain
replic
human
rectal
tumor
cell
numer
bovin
cell
bcv
propag
cell
purifi
describ
previous
hemagglutin
ha
hemagglutin
inhibit
hi
test
perform
accord
herrler
et
al
zhang
et
al
employ
chicken
mous
erythrocyt
five
mab
specif
gploo
one
mab
specif
n
protein
strain
character
previous
three
mab
specif
glycoprotein
bcv
strain
obtain
dr
snodgrass
moredun
research
institut
edingburgh
scotland
mab
use
hi
acetylesteras
inhibit
aei
assay
ae
activ
determin
accord
herrler
et
vlasak
et
al
briefli
purifi
viral
prepar
incub
bovin
submaxillari
mucin
bsm
type
sigma
mgml
pb
differ
time
point
mixtur
assay
free
acet
commerci
test
kit
boehringermannheim
frg
sampl
bsm
incub
amount
purifi
virus
serv
control
valu
control
sampl
subtract
sampl
incub
inhibit
ae
activ
perform
describ
previous
briefli
purifi
viru
prepar
incub
undilut
mab
hr
room
temperatur
follow
addit
mg
bsm
incub
temperatur
rais
min
later
amount
acet
releas
bsm
determin
describ
valu
compar
control
sampl
incub
absenc
antibodi
viral
rna
isol
infect
cell
use
isothiocyanatecesium
chlorid
gradient
describ
previous
control
rna
isol
uninfect
cell
cdna
synthesi
pcr
amplif
dna
sequenc
perform
report
recent
nucleotid
sequenc
determin
direct
least
sequenc
complet
gene
virul
avirul
strain
align
nucleotid
deduc
amino
acid
sequenc
present
fig
respect
sequenc
also
compar
recent
publish
sequenc
quebec
mebu
strain
gene
contain
larg
orf
nt
encod
predict
protein
amino
acid
residu
calcul
molecular
weight
approxim
kda
variat
among
sequenc
consist
nucleotid
substitut
frameshift
delet
insert
nonsens
mutat
observ
nt
substitut
virul
avirul
strain
eleven
occur
third
codon
posit
result
amino
acid
chang
gene
sequenc
quebec
strain
differ
base
transit
nt
caus
amino
acid
chang
mebu
strain
base
differ
sequenc
g
c
nt
result
leu
val
chang
aa
sever
featur
conserv
bcv
strain
consensu
intergen
sequenc
ctaaac
upstream
gene
two
nonoverlap
intern
orf
orfl
base
hydrophob
put
signal
sequenc
amino
acid
nterminu
extrem
hydrophob
region
amino
acid
near
cterminu
may
serv
potenti
membraneanchor
domain
stretch
hydrophil
amino
acid
cterminu
may
intravirion
domain
potenti
nlink
glycosyl
site
cystein
residu
put
activ
site
neuraminateoacetylesteras
activ
fgd
ntermin
peptid
conserv
bcv
strain
examin
whether
differ
ha
ae
activ
specifi
two
bcv
strain
purifi
virion
employ
ha
ae
assay
shown
tabl
strain
exhibit
ae
activ
measur
abil
releas
acet
substrat
bsm
similar
amount
purifi
virion
use
strain
exhibit
much
lower
ha
activ
chicken
erythrocyt
mous
erythrocyt
comparison
indic
two
bcv
strain
may
differ
bind
avid
receptor
chicken
mous
erythrocyt
mab
direct
n
protein
analyz
abil
inhibit
ha
andor
ae
activ
shown
tabl
three
mab
specif
glycoprotein
effect
inhibit
ha
activ
hi
titer
rang
wherea
ha
activ
slightli
inhibit
mab
hi
titer
likewis
ae
activ
greatli
inhibit
hespecif
mab
reduct
releas
acet
rang
bcvli
remain
unaffect
mab
specif
n
protein
neither
hi
aei
function
four
mab
specif
gpl
show
differ
reactiv
western
blot
neutral
assay
report
previous
nucleotid
sequenc
comparison
gene
virul
strain
avirul
strain
cdna
synthesi
pcr
amplif
perform
describ
previous
briefli
firststrand
cdna
synthes
revers
transcript
use
antisens
primer
repres
sequenc
posit
gene
accord
publish
sequenc
reaction
secondstrand
cdna
synthesi
doublestrand
cdna
amplif
carri
pcr
use
sens
primer
correspond
sequenc
upstream
gene
accord
publish
sequenc
two
addit
intern
primer
use
order
gener
two
overlap
fragment
dna
sequenc
dna
sequenc
carri
modifi
dideoxynucleotid
chain
termin
procedur
use
sequenas
usb
cleveland
oh
sequenc
analyz
aid
sequenc
analysi
softwar
packag
genet
comput
group
univers
wisconsin
macvector
softwar
ibi
new
ct
consensu
sequenc
ctaaat
underlin
start
stop
code
mark
asterisk
wherea
fail
inhibit
ha
activ
interestingli
mab
reactiv
bcvli
western
blot
inhibit
strain
high
titer
hi
unit
pretreat
mab
kaolin
potassium
period
heat
elimin
hi
function
caus
hi
titer
decreas
twofold
sspecif
mab
fail
inhibit
ae
activ
strain
antiserum
inhibit
ha
ae
function
strain
tabl
sequenc
comparison
reveal
gene
specifi
virul
strain
bcvli
avirul
strain
highli
conserv
despit
differ
origin
homolog
nt
aa
predict
amino
acid
sequenc
bcv
gene
ident
correspond
deduc
amino
acid
sequenc
mhvjhm
mrna
hef
hal
influenza
c
viru
respect
suggest
common
ancestr
origin
gene
bovin
respiratori
coronaviru
strain
also
highli
conserv
zhang
et
al
submit
public
interestingli
prolin
substitut
occur
signal
peptid
avirul
virul
bcvli
strain
aa
whether
substitut
could
alter
matur
intracellular
transport
glycoprotein
remain
elucid
three
addit
amino
acid
substitut
occur
protein
leu
val
aa
ser
pro
aa
thr
asn
aa
nflllrrvlv
sciig
npptnvvshl
rsdcnrwnt
npalcdsgki
sskagnsipr
sfhftdfyni
tgegqqiifi
bcvli
p
l
eglnftpyha
fkcxtsgsnd
tqvyknmavi
rsltfvnvpi
vyngsaqsta
lcksgslvln
npayiarban
fgdyyywea
dfylsgcdey
bcvli
v
ivplcifngk
flsntkyydd
sqyyfnkdtg
viyginstet
itigfdfnchylvlpsgnylaisnbllltv
ptkaiclnkr
kdftfvqvvd
srswnarqsd
bcvli
see
fig
mab
specif
glycoprotein
react
differ
two
strain
hi
aei
assay
tabl
epitop
protein
seem
continu
epitop
sinc
mab
react
western
denatur
condit
data
shown
result
impli
least
one
epitop
locat
proxim
one
three
strainspecif
amino
acid
importantli
sequenc
put
esteras
activ
domain
conserv
virul
avirul
bcv
strain
mhvjhm
influenza
c
viru
sequenc
far
indic
esteras
activ
site
essenti
structur
function
glycoprotein
howev
domain
probabl
determin
bcvvirul
sinc
conserv
virul
avirul
strain
three
mab
inhibit
ha
ae
activ
impli
two
activ
function
link
howev
exclud
possibl
two
function
domain
may
locat
differ
region
molecul
worth
note
case
influenza
bcv
bind
receptor
erythrocyt
facilit
hemagglutin
activ
report
earlier
associ
glycoprotein
sinc
glycoprotein
coronavirus
involv
viru
attach
permiss
cell
reexamin
possibl
glycoprotein
may
also
recogn
receptor
erythrocyt
facilit
hemagglutin
shown
tabl
result
confirm
previou
observ
glycoprotein
involv
agglutin
chicken
erythrocyt
activ
block
sspecif
mab
result
also
agreement
observ
isol
glycoprotein
mab
specif
inhibit
ha
activ
bcvquebec
one
possibl
explan
strain
differ
receptorbind
activ
glycoprotein
support
observ
differ
agglutin
pattern
differ
bcv
strain
chicken
erythrocyt
tabl
storz
et
unpublish
observ
also
possibl
mous
ascit
use
mab
sourc
contain
nonspecif
inhibitor
could
also
inhibit
hemagglutin
unlik
howev
pretreat
ascit
kaolin
heat
potassium
period
elimin
hi
activ
treatment
employ
elimin
nonspecif
inhibitor
sera
deriv
human
anim
may
interfer
detect
influenza
antibodi
antisspecif
mab
react
glycoprotein
western
blot
evid
argu
possibl
ascit
contamin
antih
mab
consequ
result
suggest
bcv
glycoprotein
involv
agglutin
chicken
erythrocyt
may
explain
ibv
strain
lack
glycoprotein
exhibit
ha
activ
receptor
determin
chicken
etythrocyt
specif
bcv
protein
appear
similar
protein
howev
exclud
possibl
anti
mab
inhibit
ha
activ
bcv
steric
hindranc
antibodi
molecul
protein
presenc
bcv
hemagglutin
coronavirus
lead
us
hypothes
glycoprotein
may
share
receptorbind
function
glycoprotein
two
molecul
act
synergist
viral
infect
experi
util
clone
gene
express
character
function
properti
includ
bind
ligand
host
cell
provid
insight
bcv
molecular
pathogenesi
